Literature DB >> 16787750

Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.

Thorsten Gerstner1, Deike Buesing, Elke Longin, Claudia Bendl, Dieter Wenzel, Brigitte Scheid, Gisela Goetze, Alfons Macke, Gerhard Lippert, Wolfgang Klostermann, Geert Mayer, Regine Augspach-Hofmann, Sabine Fitzek, Carl-Albrecht Haensch, Markus Reuland, Stephan A Koenig.   

Abstract

Valproic acid (VPA) is a broad-spectrum antiepileptic drug and is usually well-tolerated. Rare serious complications may occur in some patients, including haemorrhagic pancreatitis, bone marrow suppression, VPA-induced hepatotoxicity and VPA-induced encephalopathy. The typical signs of VPA-induced encephalopathy are impaired consciousness, sometimes marked EEG background slowing, increased seizure frequency, with or without hyperammonemia. There is still no proof of causative effect of VPA in patients with encephalopathy, but only of an association with an assumed causal relation. We report 19 patients with VPA-associated encephalopathy in Germany from the years 1994 to 2003, none of whom had been published previously.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787750     DOI: 10.1016/j.seizure.2006.05.007

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  17 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

Review 2.  Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature.

Authors:  Estee Chan; Fiona McQueen
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

3.  Valproate-Induced Hyperammonemic Encephalopathy Following Accidental Ingestion in a Toddler.

Authors:  Moftah Alhagamhmad; Aisha Elarwah; Alia Alhassony; Shirin Alougly; Hamza Milad; Aziza Dehoam; Suliman Elbrgathy; Nuri Shembesh; Emhemed Mousa; Abdulhamid ElShiky
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

4.  Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.

Authors:  Daniel A Gorman; David M Gardner; Andrea L Murphy; Mark Feldman; Stacey A Bélanger; Margaret M Steele; Khrista Boylan; Kate Cochrane-Brink; Roxanne Goldade; Paul R Soper; Judy Ustina; Tamara Pringsheim
Journal:  Can J Psychiatry       Date:  2015-02       Impact factor: 4.356

5.  Role of Free Valproic Acid Levels in a Patient with Severe Hypoalbuminemia: A Case Report.

Authors:  Tanveer Brar; Sherif Hanafy Mahmoud
Journal:  Can J Hosp Pharm       Date:  2022-07-04

6.  Encephalopathy in an infant with infantile spasms: possible role of valproate toxicity.

Authors:  Shobhana Sivathanu; Sowmya Sampath; Madhubala Veerasamy; Satheeshkumar Sunderkumar
Journal:  BMJ Case Rep       Date:  2014-04-15

7.  Valproic acid-induced abnormal behavior.

Authors:  Nanjangud Chandrashekar Nagalakshmi; Madhan Ramesh; Gurumurthy Parthasarathi; Anand Harugeri; Mary Sam Christy; Belur Seshachala Keshava
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

Review 8.  Molecular and therapeutic potential and toxicity of valproic acid.

Authors:  Sébastien Chateauvieux; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  J Biomed Biotechnol       Date:  2010-07-29

9.  Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness.

Authors:  Astrid Bertsche; Martina P Neininger; Anna J Dahse; Steffen Syrbe; Matthias K Bernhard; Roberto Frontini; Wieland Kiess; Thilo Bertsche; Andreas Merkenschlager
Journal:  Eur J Pediatr       Date:  2013-08-11       Impact factor: 3.183

10.  Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.

Authors:  Eva Stuebner; Ekawat Vichayanrat; David A Low; Christopher J Mathias; Stefan Isenmann; Carl-Albrecht Haensch
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.